Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Block Inc (XYZ) Price & Performance

Medpace Holdings IncTrade
Block IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Block Inc — how do they compare? Medpace Holdings Inc trades at $532.89 (market cap $15.08B), while Block Inc trades at $80.11 (market cap $47.19B). The key difference: Block Inc is far larger — about 3.1× Medpace Holdings Inc's market cap, and Block Inc is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.

MEDPXYZ
Market Cap
$15.08B$47.19B
Sector
TechnologyTechnology
52-Week High
$620.59$81.81
52-Week Low
$308.88$49.04
Enterprise Value
$14.55B$42.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.

MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.

Block Inc

Block (XYZ) trades at $79.72, down 0.28% on the day, with strong technical momentum as moving averages signal bullish sentiment. The company reported mixed Q1 2026 earnings, beating expectations with $0.85 EPS versus $0.675 forecast, while revenue reached $24.19 billion in 2025. Recent news highlights include a $45 million settlement over Cash App fraud allegations and continued strength in Square and Cash App segments.

The stock offers 12% upside to the $89.53 consensus price target, supported by 74% analyst buy ratings. However, elevated P/E of 62.45 and declining net income margins from 12.01% to 5.39% pose valuation concerns. Key risks include rising credit losses and regulatory scrutiny, while AI integration and payment growth present long-term opportunities.

Returns comparison

Trailing returns across standard periods

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About Block Inc

Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom

Read more on XYZ